Brighter Future for
Alzheimer's Disease Early Warning
Long-term Healthcare Savings
Clinical Research Support
Collaborate with the Janus AI Community
Janus AI empowers healthcare professionals to practice proactive medicine with an integrated early warning software tool to assess a patient's risk for the development of Alzheimer's disease before symptom onset.
Over 10% of persons over the age of 65 are affected by Alzheimer's disease and many are diagnosed after loss of cognitive function. Janus AI allows patients to stay ahead of their disease progression and to retain their autonomy for longer with a long-term healthcare plan.
Janus AI will be a revolutionary artificial intelligence technology meant to change the landscape of Alzheimer's disease treatment for the better. The Janus AI Community will be available to help healthcare professionals navigate patient counseling, to develop long-term healthcare plans, and to collaborate in our think tank.
Our software will also enhance Alzheimer's research by providing dementia risk assessments of trial participants, thus supporting clinical trial results.
Identifying Patients at Greatest Risk for the
Development of Alzheimer's Disease
Machine learning model trained on established data from researchers around the world
Ease of Use
Seamless integration into electronic health records for simplified results
Collaborate with other healthcare professionals